← All companies

IRD

Opus Genetics, Inc.

IRD Nasdaq Pharmaceutical Preparations EDGAR ↗

$3.64

-0.20 -5.21%

Key statistics

from XBRL data in SEC filings

Market cap

$296M

Revenue (TTM)

$12.0M

Net income (TTM)

-$107M

EPS (TTM)

$-1.31

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$60.0M

Total assets

$66.8M

Gross margin

—

52-week range

$1.04 – $5.81

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Regulation FD disclosure Jun 16, 2026 8-K Regulation FD disclosure Jun 16, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 8-K Took on a direct financial obligation Apr 24, 2026 8-K Shareholder vote results Apr 22, 2026 8-K Director or officer change Apr 7, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Apr 7, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Results of operations (earnings release) Mar 10, 2026 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Amended charter or bylaws; Other events Feb 19, 2026 8-K Regulation FD disclosure Jan 12, 2026 8-K Regulation FD disclosure Jan 8, 2026 8-K Other events Dec 19, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Entered a material agreement; Other events Nov 6, 2025 8-K Regulation FD disclosure; Other events Nov 6, 2025 8-K Regulation FD disclosure; Other events Sep 30, 2025 8-K Director or officer change; Regulation FD disclosure Sep 2, 2025 8-K Unregistered sale of equity Aug 25, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Results of operations (earnings release) Aug 13, 2025 8-K Entered a material agreement; Regulation FD disclosure Jul 23, 2025 8-K Other events Jun 26, 2025 8-K Director or officer change Jun 25, 2025 8-K Regulation FD disclosure Jun 23, 2025 8-K Entered a material agreement Jun 20, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release) May 15, 2025 8-K Shareholder vote results May 1, 2025 8-K Terminated a material agreement Apr 4, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release) Mar 31, 2025 8-K Unregistered sale of equity; Other events Mar 24, 2025 8-K Results of operations (earnings release) Mar 20, 2025 8-K Amended charter or bylaws; Other events Mar 20, 2025 8-K Other events Mar 4, 2025 8-K Director or officer change Jan 24, 2025 8-K Other events Jan 23, 2025